Trading a PRME straddle lets you take a pure volatility position on Prime Medicine Inc without committing to a direction. Prime Medicine Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate PRME straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on PRME profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Prime Medicine Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the PRME straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the PRME straddle is the cleanest expression of that view. Our scanner prices every PRME straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a PRME straddle into a catalyst or short a PRME straddle to harvest decay, the options straddle setups that matter are all in one place.
